Search - tctmd.com

Displaying 41 - 60 of 649

Sort: Relevancy | Date

Presentation THT 2025

Atrial Flow Regulator for Controlled Interatrial, Right-to-Left Shunting in Patients With Severe Primary Pulmonary Arterial Hypertension: The AFR PROPHET Registry

Presenter: Jozef Bartunek

February 12, 2025

News Daily News

High Survival Rates Seen in Sports-Related Cardiac Arrest in Canada

Michael O'Riordan

February 10, 2025

News Daily News

Use of Secondary CVD Prevention Meds Still Meager Worldwide

Caitlin E. Cox

February 03, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2025

Shelley Wood

January 31, 2025

News Daily News

Early Actions by Trump Administration Sow Uncertainty for CV Research

Todd Neale

January 30, 2025

News Daily News

AHA Stats Show CV Health of Americans Remains Dire

Michael O'Riordan

January 28, 2025

News Conference News STS 2025

Second Annual STS Compensation Survey Finds Gaps Persist By Gender

Yael L. Maxwell

January 28, 2025

News Daily News

Aspirin Use for Primary Prevention Declining in US: NHANES

Michael O'Riordan

January 24, 2025

News Daily News

Global Study Shows Sugary Drinks Boosting Diabetes and CVD at Alarming Rates

L.A. McKeown

January 10, 2025

Presentation TCT 2024

TCT 793: Unraveling the Connection: Central Obesity, Atherosclerosis, and Heart Failure in African Americans: Focusing on the Mediating Role of Atherosclerosis

Presenter: Chun-Wei Lee

October 29, 2024

News Opinion CV Team Dispatch

October 2024 Dispatch for the CV Team

L.A. McKeown

October 25, 2024

News Daily News

The Cardiovascular Consequences of War

Todd Neale

October 23, 2024

News Daily News

Low Adherence to Secondary Prevention Recommendations Worldwide: INTERASPIRE

Yael L. Maxwell

September 23, 2024

News Opinion Over the Wire

Racism Is Still Here—Some of Us Are Just Too Blind to See It

Mamas Mamas, BMBCh

August 23, 2024

News Daily News

Lp(a) Still Low Almost 1 Year After Last Olpasiran Injection: OCEAN(a)-DOSE

Yael L. Maxwell

August 19, 2024

News Daily News

ACE-PROTAVI Data Solidify Protamine’s Role in Aortic Interventions

Caitlin E. Cox

August 16, 2024

News Opinion Fellow Talk

What Rowing in the Olympics Taught Me About Training in Cardiothoracic Surgery

Veronica Toro Arana, MD

August 06, 2024

News Daily News

AAA-Related Mortality Rates Decline, With Reductions Seen in All Groups

Michael O'Riordan

July 29, 2024

News Daily News

Stressors From All Sides Impact Women’s CV Risk, Review Asserts

Caitlin E. Cox

July 10, 2024

News Conference News ACC 2024

NOW PUBLISHED - LIBerate-HR: Lerodalcibep Lowers LDL More Sharply Than Placebo Over 1 Year

Yael L. Maxwell

July 03, 2024

Advertisement

Atrial Flow Regulator for Controlled Interatrial, Right-to-Left Shunting in Patients With Severe Primary Pulmonary Arterial Hypertension: The AFR PROPHET Registry

High Survival Rates Seen in Sports-Related Cardiac Arrest in Canada

Use of Secondary CVD Prevention Meds Still Meager Worldwide

TCTMD’s Top 10 Most Popular Stories for January 2025

Early Actions by Trump Administration Sow Uncertainty for CV Research

AHA Stats Show CV Health of Americans Remains Dire

Second Annual STS Compensation Survey Finds Gaps Persist By Gender

Aspirin Use for Primary Prevention Declining in US: NHANES

Global Study Shows Sugary Drinks Boosting Diabetes and CVD at Alarming Rates

TCT 793: Unraveling the Connection: Central Obesity, Atherosclerosis, and Heart Failure in African Americans: Focusing on the Mediating Role of Atherosclerosis

October 2024 Dispatch for the CV Team

The Cardiovascular Consequences of War

Low Adherence to Secondary Prevention Recommendations Worldwide: INTERASPIRE

Racism Is Still Here—Some of Us Are Just Too Blind to See It

Lp(a) Still Low Almost 1 Year After Last Olpasiran Injection: OCEAN(a)-DOSE

ACE-PROTAVI Data Solidify Protamine’s Role in Aortic Interventions

What Rowing in the Olympics Taught Me About Training in Cardiothoracic Surgery

AAA-Related Mortality Rates Decline, With Reductions Seen in All Groups

Stressors From All Sides Impact Women’s CV Risk, Review Asserts

NOW PUBLISHED - LIBerate-HR: Lerodalcibep Lowers LDL More Sharply Than Placebo Over 1 Year

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content